Yeah I think the word shortly should mean weeks rather than months, but the biotech industry is one of snail like progression. It's an unfortunate process, especially when you have a drug like CUV's which would provide much benefit to many people around the world.
Alot to be learnt from this stock but for the time being let's cross our fingers this phase III is excellent and that approval comes swiftly.
another delay ....., page-8
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.53 |
Change
0.290(1.90%) |
Mkt cap ! $777.7M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.55 | $15.03 | $861.9K | 56.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 164 | $15.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.53 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |